These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11594564)

  • 1. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.
    Berger CL; Longley J; Hanlon D; Girardi M; Edelson R
    Ann N Y Acad Sci; 2001 Sep; 941():106-22. PubMed ID: 11594564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor.
    Berger CL; Longley BJ; Imaeda S; Christensen I; Heald P; Edelson RL
    Int J Cancer; 1998 May; 76(3):304-11. PubMed ID: 9579563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma.
    Winter D; Fiebiger E; Meraner P; Auer H; Brna C; Strohal R; Trautinger F; Knobler R; Fischer GF; Stingl G; Maurer D
    J Immunol; 2003 Sep; 171(5):2714-24. PubMed ID: 12928425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA class I dependent immunogenic peptides from clonotypic TCRbeta expressed in cutaneous T-cell lymphoma.
    Zeng J; Müller-Berghaus J; Nguyen XD; Klüter H; Schönhaber H; Song M; Schwinn N; Schadendorf D; Goerdt S; Eichmüller S; Dippel E
    Int J Cancer; 2006 Nov; 119(10):2476-80. PubMed ID: 16858680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and kinetic basis for heightened immunogenicity of T cell vaccines.
    Chen JL; Stewart-Jones G; Bossi G; Lissin NM; Wooldridge L; Choi EM; Held G; Dunbar PR; Esnouf RM; Sami M; Boulter JM; Rizkallah P; Renner C; Sewell A; van der Merwe PA; Jakobsen BK; Griffiths G; Jones EY; Cerundolo V
    J Exp Med; 2005 Apr; 201(8):1243-55. PubMed ID: 15837811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
    Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
    J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stable single-chain variable fragment expressing transfectoma demonstrates induction of idiotype-specific cytotoxic T-cells during early growth stages of a murine B-lymphoma.
    Laxmanan S; Stuart GW; Ghosh SK
    Cancer Immunol Immunother; 2001 Oct; 50(8):437-44. PubMed ID: 11726138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
    Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
    Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination.
    Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
    J Immunol; 2000 Apr; 164(8):4011-7. PubMed ID: 10754292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens.
    Berger CL; Wang N; Christensen I; Longley J; Heald P; Edelson RL
    J Invest Dermatol; 1996 Sep; 107(3):392-7. PubMed ID: 8751976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.
    Parkhurst MR; Joo J; Riley JP; Yu Z; Li Y; Robbins PF; Rosenberg SA
    Clin Cancer Res; 2009 Jan; 15(1):169-80. PubMed ID: 19118044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas.
    Bagot M; Nikolova M; Schirm-Chabanette F; Wechsler J; Boumsell L; Bensussan A
    Ann N Y Acad Sci; 2001 Sep; 941():31-8. PubMed ID: 11594580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity.
    Casanova JL; Cerottini JC; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald HR; Lemonnier F; Malissen B; Maryanski JL
    J Exp Med; 1992 Aug; 176(2):439-47. PubMed ID: 1380061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.
    Danska JS; Livingstone AM; Paragas V; Ishihara T; Fathman CG
    J Exp Med; 1990 Jul; 172(1):27-33. PubMed ID: 1694219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
    Hardy LL; Wick DA; Webb JR
    J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition.
    Brändle D; Bürki K; Wallace VA; Rohrer UH; Mak TW; Malissen B; Hengartner H; Pircher H
    Eur J Immunol; 1991 Sep; 21(9):2195-202. PubMed ID: 1716213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.